Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 1863 entries
View as:

Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003055 Org: User:
Start: 06/30/97 End: 04/30/01 Due: 04/30/02

A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03432806 Org: User:
Start: 11/28/17 End: 11/30/25 Due: 11/30/26

A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03465618 Org: User:
Start: 03/07/18 End: 03/31/26 Due: 03/31/27

Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT05873205 Org: User:
Start: 07/21/23 End: 06/29/26 Due: 06/29/27

A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing

Phase: N/A Priority: Normal
NCT ID: NCT03133650 Org: User:
Start: 04/26/17 End: 02/23/26 Due: 02/23/27

Estrogen, Diet, Genetics and Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00587886 Org: User:
Start: 09/25/01 End: 12/31/25 Due: 12/31/26

Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04774419 Org: User:
Start: 04/02/21 End: 02/28/26 Due: 02/28/27

Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene

Phase: N/A Priority: Normal
NCT ID: NCT00588445 Org: User:
Start: 06/30/04 End: 09/30/10 Due: 09/30/11

Collection of Tumor Tissue, Blood and Spinal Fluid From Patients With Brain or Spine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00580463 Org: User:
Start: 01/31/00 End: 03/31/09 Due: 03/31/10

Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)

Phase: N/A Priority: Normal
NCT ID: NCT01183065 Org: User:
Start: 08/31/10 End: 04/30/14 Due: 04/30/15

Breast MRI Spectroscopy, Department of Defense (DOD)

Phase: N/A Priority: Normal
NCT ID: NCT00582569 Org: User:
Start: 02/28/06 End: 05/31/13 Due: 05/31/14

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00003658 Org: User:
Start: 09/30/98 End: 10/31/05 Due: 10/31/06

Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRI

Phase: N/A Priority: Normal
NCT ID: NCT02462460 Org: User:
Start: 06/30/15 End: 06/30/25 Due: 06/30/26

Copanlisib with Ibrutinib for Patients with Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL)

Phase: N/A Priority: Normal
NCT ID: NCT03581942 Org: User:
Start: 08/23/18 End: 07/31/25 Due: 07/31/26

Study of the Safety and Efficacy of Ruxolitinib Cream for Non-Sclerotic Chronic Cutaneous Graft-Versus-Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT03954236 Org: User:
Start: 05/14/19 End: 03/05/24 Due: 03/05/25

A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)

Phase: N/A Priority: Normal
NCT ID: NCT07001384 Org: User:
Start: 06/30/25 End: 06/30/31 Due: 06/30/32

Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor

Phase: N/A Priority: Normal
NCT ID: NCT02880293 Org: User:
Start: 08/23/16 End: 11/20/23 Due: 11/20/24

Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00003754 Org: User:
Start: 09/30/98 End: 07/31/01 Due: 07/31/02

The Patient-Perspective of Complications After Colon and Rectum Surgery: A Qualitative Analysis

Phase: N/A Priority: Normal
NCT ID: NCT02836535 Org: User:
Start: 07/31/16 End: 06/28/17 Due: 06/28/18

Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00040833 Org: User:
Start: 02/28/02 End: 06/30/03 Due: 06/30/04

Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00014378 Org: User:
Start: 10/31/00 End: 12/31/07 Due: 12/31/08

Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment

Phase: N/A Priority: Normal
NCT ID: NCT02422550 Org: User:
Start: 04/09/15 End: 04/30/26 Due: 04/30/27

Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00390416 Org: User:
Start: 10/31/06 End: 01/31/12 Due: 01/31/13

Detection of Peritoneal Micrometastasis in Gastric and Pancreatic Cancer in Peritoneal Wash Samples

Phase: N/A Priority: Normal
NCT ID: NCT00582062 Org: User:
Start: 03/31/06 End: 05/02/23 Due: 05/02/24

Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00084812 Org: User:
Start: 03/31/04 End: 02/28/09 Due: 02/28/10